Squarepoint’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $798K | Sell |
2,446
-3,822
| -61% | -$1.25M | ﹤0.01% | 1652 |
|
2025
Q1 | $1.69M | Sell |
6,268
-121,429
| -95% | -$32.8M | ﹤0.01% | 1248 |
|
2024
Q4 | $30M | Buy |
127,697
+84,996
| +199% | +$20M | 0.03% | 259 |
|
2024
Q3 | $11.7M | Sell |
42,701
-56,093
| -57% | -$15.4M | 0.02% | 452 |
|
2024
Q2 | $24M | Sell |
98,794
-481,647
| -83% | -$117M | 0.04% | 254 |
|
2024
Q1 | $86.7M | Buy |
580,441
+244,615
| +73% | +$36.6M | 0.15% | 50 |
|
2023
Q4 | $64.3M | Buy |
335,826
+98,192
| +41% | +$18.8M | 0.12% | 91 |
|
2023
Q3 | $42.1M | Buy |
237,634
+70,011
| +42% | +$12.4M | 0.1% | 122 |
|
2023
Q2 | $31.8M | Buy |
167,623
+34,395
| +26% | +$6.53M | 0.1% | 131 |
|
2023
Q1 | $26.7M | Buy |
133,228
+131,019
| +5,931% | +$26.2M | 0.11% | 134 |
|
2022
Q4 | $525K | Sell |
2,209
-35,541
| -94% | -$8.45M | ﹤0.01% | 1435 |
|
2022
Q3 | $7.56M | Sell |
37,750
-87,350
| -70% | -$17.5M | 0.04% | 348 |
|
2022
Q2 | $18.2M | Buy |
125,100
+87,662
| +234% | +$12.8M | 0.1% | 150 |
|
2022
Q1 | $6.11M | Buy |
+37,438
| New | +$6.11M | 0.03% | 431 |
|
2021
Q3 | – | Hold |
0
| – | – | – | 2202 |
|
2021
Q2 | – | Hold |
0
| – | – | – | 2583 |
|
2021
Q1 | – | Sell |
-23,308
| Closed | -$3.03M | – | 2515 |
|
2020
Q4 | $3.03M | Sell |
23,308
-4,183
| -15% | -$544K | 0.02% | 580 |
|
2020
Q3 | $4M | Buy |
27,491
+24,359
| +778% | +$3.55M | 0.05% | 395 |
|
2020
Q2 | $464K | Sell |
3,132
-8,604
| -73% | -$1.27M | 0.01% | 1341 |
|
2020
Q1 | $1.28M | Sell |
11,736
-66,557
| -85% | -$7.24M | 0.03% | 616 |
|
2019
Q4 | $9.02M | Buy |
+78,293
| New | +$9.02M | 0.05% | 324 |
|
2019
Q3 | – | Sell |
-21,792
| Closed | -$1.58M | – | 2205 |
|
2019
Q2 | $1.58M | Buy |
21,792
+9,472
| +77% | +$687K | 0.02% | 968 |
|
2019
Q1 | $1.15M | Buy |
+12,320
| New | +$1.15M | 0.01% | 1026 |
|
2018
Q4 | – | Sell |
-74,930
| Closed | -$6.56M | – | 1893 |
|
2018
Q3 | $6.56M | Sell |
74,930
-15,188
| -17% | -$1.33M | 0.08% | 324 |
|
2018
Q2 | $8.88M | Buy |
90,118
+61,372
| +213% | +$6.04M | 0.12% | 260 |
|
2018
Q1 | $3.42M | Buy |
+28,746
| New | +$3.42M | 0.05% | 406 |
|
2017
Q3 | – | Sell |
-26,530
| Closed | -$2.12M | – | 1576 |
|
2017
Q2 | $2.12M | Buy |
26,530
+15,730
| +146% | +$1.25M | 0.04% | 499 |
|
2017
Q1 | $554K | Sell |
10,800
-700
| -6% | -$35.9K | 0.02% | 811 |
|
2016
Q4 | $431K | Buy |
11,500
+4,500
| +64% | +$169K | 0.02% | 922 |
|
2016
Q3 | $474K | Buy |
+7,000
| New | +$474K | 0.03% | 583 |
|
2016
Q2 | – | Sell |
-8,000
| Closed | -$502K | – | 1080 |
|
2016
Q1 | $502K | Buy |
8,000
+2,800
| +54% | +$176K | 0.04% | 627 |
|
2015
Q4 | $490K | Buy |
+5,200
| New | +$490K | 0.05% | 549 |
|